推荐产品
描述
Powered by Eupheria Biotech
產品線
MISSION®
形狀
lyophilized powder
esiRNA cDNA 標靶序列
GCCTGGCTAGCAACACTCACTGTCAGTTAGGCAGTCCTGATGTATCTGTACATAGACCATTTGCCTTATATTGGCAAATGTAAGTTGTTTCTATGAAACAAACATATTTAGTTCACTATTATATAGTGGGTTATATTAAAAGAAAAGAAGAAAAATATCTAATTTCTCTTGGCAGATTTGCATATTTCATACCCAGGTATCTGGGATCTAGACATCTGAATTTGATCTCAATGGTAACATTGCCTTCAATTAACAGTAGCTTTTGAGTAGGAAAGGACTTTGATTTGTGGCACAAAACATTATTAATATAGCTATTGACAGTTTCAAAGCAGGTAAATTGTAAATGTTTCTTTAAGAAAAAGCATGTGAAAGGAAAAAGGTAAATACAGCATTGAGGCTTCATTTGGCCTTAGTCCCTG
Ensembl | 人類登錄號
NCBI登錄號
運輸包裝
ambient
儲存溫度
−20°C
基因資訊
human ... NFKBIZ(64332) , NFKBIZ(64332)
相关类别
一般說明
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
法律資訊
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
10 - Combustible liquids
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Science advances, 6(30), eabb6049-eabb6049 (2020-08-25)
Systemic antibodies targeting tumor necrosis factor-α (TNF-α) and interleukin-17A (IL-17A) are effective in plaque psoriasis. Despite their popularity, safety concerns pose a challenge for systemic biologics. While anti-TNF-α and anti-IL-17A antibodies effectively inhibit respective proteins, we hypothesize that an approach
JCI insight, 5(24) (2020-12-18)
Sepsis is the leading cause of acute kidney injury (AKI). However, the pathogenesis of septic AKI remains largely unclear. Here, we demonstrate a significant decrease of microRNA-376b (miR-376b) in renal tubular cells in mice with septic AKI. Urinary miR-376b in
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门